Selected research
Industry Research
Clinical Bioanalysis Industry Research Report 2026
Market perspective
The global Clinical Bioanalysis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Clinical Bioanalysis market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Clinical Bioanalysis market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Clinical Bioanalysis market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Clinical Bioanalysis include PPD, Inc., WuXi AppTec, Laboratory Corporation of America, Medpace, Charles River Laboratories International, Inc., Syneos Health, Intertek Group, ICON plc and IQVIA, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Clinical Bioanalysis market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Clinical Bioanalysis.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Clinical Bioanalysis Market by Company
PPD, Inc.
WuXi AppTec
Laboratory Corporation of America
Medpace
Charles River Laboratories International, Inc.
Syneos Health
Intertek Group
ICON plc
IQVIA
Eurofins Scientific
SGS SA Toxikon, Inc.
PRA HEALTH SCIENCES
Pace Analytical Services
Clinical Bioanalysis Segment by Type
Pre-Clinical Studies
Clinical Studies
Clinical Bioanalysis Segment by Application
Pharmaceutical companies
Biotechnology companies
CROs
Hospital
Diagnostic Centers
Clinical Bioanalysis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Bioanalysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Bioanalysis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Bioanalysis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Clinical Bioanalysis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pre-Clinical Studies
- Clinical Studies
Applications
- Pharmaceutical companies
- Biotechnology companies
- CROs
- Hospital
- Diagnostic Centers
Companies covered
- PPD, Inc.
- WuXi AppTec
- Laboratory Corporation of America
- Medpace
- Charles River Laboratories International, Inc.
- Syneos Health
- Intertek Group
- ICON plc
- IQVIA
- Eurofins Scientific
- SGS SA Toxikon, Inc.
- PRA HEALTH SCIENCES
- Pace Analytical Services
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Clinical Bioanalysis by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Pre-Clinical Studies
- 2.2.3 Clinical Studies
- 2.3 Clinical Bioanalysis by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical companies
- 2.3.3 Biotechnology companies
- 2.3.4 CROs
- 2.3.5 Hospital
- 2.3.6 Diagnostic Centers
- 2.4 Assumptions and Limitations
3 Clinical Bioanalysis Breakdown Data by Type
- 3.1 Global Clinical Bioanalysis Historic Market Size by Type (2021-2026)
- 3.2 Global Clinical Bioanalysis Forecasted Market Size by Type (2027-2032)
4 Clinical Bioanalysis Breakdown Data by Application
- 4.1 Global Clinical Bioanalysis Historic Market Size by Application (2021-2026)
- 4.2 Global Clinical Bioanalysis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Clinical Bioanalysis Market Perspective (2021-2032)
- 5.2 Global Clinical Bioanalysis Growth Trends by Region
- 5.2.1 Global Clinical Bioanalysis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Clinical Bioanalysis Historic Market Size by Region (2021-2026)
- 5.2.3 Clinical Bioanalysis Forecasted Market Size by Region (2027-2032)
- 5.3 Clinical Bioanalysis Market Dynamics
- 5.3.1 Clinical Bioanalysis Industry Trends
- 5.3.2 Clinical Bioanalysis Market Drivers
- 5.3.3 Clinical Bioanalysis Market Challenges
- 5.3.4 Clinical Bioanalysis Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Clinical Bioanalysis Players by Revenue
- 6.1.1 Global Top Clinical Bioanalysis Players by Revenue (2021-2026)
- 6.1.2 Global Clinical Bioanalysis Revenue Market Share by Players (2021-2026)
- 6.2 Global Clinical Bioanalysis Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Clinical Bioanalysis Head Office and Area Served
- 6.4 Global Clinical Bioanalysis Players, Product Type & Application
- 6.5 Global Clinical Bioanalysis Manufacturers Established Date
- 6.6 Global Clinical Bioanalysis Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Clinical Bioanalysis Market Size (2021-2032)
- 7.2 North America Clinical Bioanalysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Clinical Bioanalysis Market Size by Country (2021-2026)
- 7.4 North America Clinical Bioanalysis Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Clinical Bioanalysis Market Size (2021-2032)
- 8.2 Europe Clinical Bioanalysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Clinical Bioanalysis Market Size by Country (2021-2026)
- 8.4 Europe Clinical Bioanalysis Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Clinical Bioanalysis Market Size (2021-2032)
- 9.2 Asia-Pacific Clinical Bioanalysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Clinical Bioanalysis Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Clinical Bioanalysis Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Clinical Bioanalysis Market Size (2021-2032)
- 10.2 South America Clinical Bioanalysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Clinical Bioanalysis Market Size by Country (2021-2026)
- 10.4 South America Clinical Bioanalysis Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Clinical Bioanalysis Market Size (2021-2032)
- 11.2 Middle East & Africa Clinical Bioanalysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Clinical Bioanalysis Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Clinical Bioanalysis Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 PPD, Inc.
- 12.1.1 PPD, Inc. Company Information
- 12.1.2 PPD, Inc. Business Overview
- 12.1.3 PPD, Inc. Revenue in Clinical Bioanalysis Business (2021-2026)
- 12.1.4 PPD, Inc. Clinical Bioanalysis Product Portfolio
- 12.1.5 PPD, Inc. Recent Developments
- 12.2 WuXi AppTec
- 12.2.1 WuXi AppTec Company Information
- 12.2.2 WuXi AppTec Business Overview
- 12.2.3 WuXi AppTec Revenue in Clinical Bioanalysis Business (2021-2026)
- 12.2.4 WuXi AppTec Clinical Bioanalysis Product Portfolio
- 12.2.5 WuXi AppTec Recent Developments
- 12.3 Laboratory Corporation of America
- 12.3.1 Laboratory Corporation of America Company Information
- 12.3.2 Laboratory Corporation of America Business Overview
- 12.3.3 Laboratory Corporation of America Revenue in Clinical Bioanalysis Business (2021-2026)
- 12.3.4 Laboratory Corporation of America Clinical Bioanalysis Product Portfolio
- 12.3.5 Laboratory Corporation of America Recent Developments
- 12.4 Medpace
- 12.4.1 Medpace Company Information
- 12.4.2 Medpace Business Overview
- 12.4.3 Medpace Revenue in Clinical Bioanalysis Business (2021-2026)
- 12.4.4 Medpace Clinical Bioanalysis Product Portfolio
- 12.4.5 Medpace Recent Developments
- 12.5 Charles River Laboratories International, Inc.
- 12.5.1 Charles River Laboratories International, Inc. Company Information
- 12.5.2 Charles River Laboratories International, Inc. Business Overview
- 12.5.3 Charles River Laboratories International, Inc. Revenue in Clinical Bioanalysis Business (2021-2026)
- 12.5.4 Charles River Laboratories International, Inc. Clinical Bioanalysis Product Portfolio
- 12.5.5 Charles River Laboratories International, Inc. Recent Developments
- 12.6 Syneos Health
- 12.6.1 Syneos Health Company Information
- 12.6.2 Syneos Health Business Overview
- 12.6.3 Syneos Health Revenue in Clinical Bioanalysis Business (2021-2026)
- 12.6.4 Syneos Health Clinical Bioanalysis Product Portfolio
- 12.6.5 Syneos Health Recent Developments
- 12.7 Intertek Group
- 12.7.1 Intertek Group Company Information
- 12.7.2 Intertek Group Business Overview
- 12.7.3 Intertek Group Revenue in Clinical Bioanalysis Business (2021-2026)
- 12.7.4 Intertek Group Clinical Bioanalysis Product Portfolio
- 12.7.5 Intertek Group Recent Developments
- 12.8 ICON plc
- 12.8.1 ICON plc Company Information
- 12.8.2 ICON plc Business Overview
- 12.8.3 ICON plc Revenue in Clinical Bioanalysis Business (2021-2026)
- 12.8.4 ICON plc Clinical Bioanalysis Product Portfolio
- 12.8.5 ICON plc Recent Developments
- 12.9 IQVIA
- 12.9.1 IQVIA Company Information
- 12.9.2 IQVIA Business Overview
- 12.9.3 IQVIA Revenue in Clinical Bioanalysis Business (2021-2026)
- 12.9.4 IQVIA Clinical Bioanalysis Product Portfolio
- 12.9.5 IQVIA Recent Developments
- 12.10 Eurofins Scientific
- 12.10.1 Eurofins Scientific Company Information
- 12.10.2 Eurofins Scientific Business Overview
- 12.10.3 Eurofins Scientific Revenue in Clinical Bioanalysis Business (2021-2026)
- 12.10.4 Eurofins Scientific Clinical Bioanalysis Product Portfolio
- 12.10.5 Eurofins Scientific Recent Developments
- 12.11 SGS SA Toxikon, Inc.
- 12.11.1 SGS SA Toxikon, Inc. Company Information
- 12.11.2 SGS SA Toxikon, Inc. Business Overview
- 12.11.3 SGS SA Toxikon, Inc. Revenue in Clinical Bioanalysis Business (2021-2026)
- 12.11.4 SGS SA Toxikon, Inc. Clinical Bioanalysis Product Portfolio
- 12.11.5 SGS SA Toxikon, Inc. Recent Developments
- 12.12 PRA HEALTH SCIENCES
- 12.12.1 PRA HEALTH SCIENCES Company Information
- 12.12.2 PRA HEALTH SCIENCES Business Overview
- 12.12.3 PRA HEALTH SCIENCES Revenue in Clinical Bioanalysis Business (2021-2026)
- 12.12.4 PRA HEALTH SCIENCES Clinical Bioanalysis Product Portfolio
- 12.12.5 PRA HEALTH SCIENCES Recent Developments
- 12.13 Pace Analytical Services
- 12.13.1 Pace Analytical Services Company Information
- 12.13.2 Pace Analytical Services Business Overview
- 12.13.3 Pace Analytical Services Revenue in Clinical Bioanalysis Business (2021-2026)
- 12.13.4 Pace Analytical Services Clinical Bioanalysis Product Portfolio
- 12.13.5 Pace Analytical Services Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst